Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2023-09-05 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2023
Transaction in Own Shares Classification · 1% confidence The document consists of detailed tables reporting transactions involving the issuer's shares ('IPSEN'). The tables list the 'Day of transaction', 'Identification code of financial instrument', 'Aggregated daily volume (in number of shares)', 'Daily weighted average price', and specific transaction details including 'Price per transaction', 'Currency', and 'Acquired volume'. The presence of columns like 'Purpose of buy back' and the nature of the data (daily transaction logs of share movements) strongly indicates a report detailing the company's own share transactions. This aligns directly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities.
2023-09-05 English
Ipsen nominates Pascal Touchon to its Board of Directors as new independent director
Board/Management Information Classification · 1% confidence The document is a press release announcing a change in the company's Board of Directors: the cooptation of a new independent director and the stepping down of an existing one. This directly relates to the composition and governance structure of the company's leadership. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' This is a perfect match. It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as the subject matter is highly specific to board composition.
2023-09-04 English
Ipsen nomme Pascal Touchon en tant que nouvel administrateur indépendant au sein de son Conseil d’administration
Board/Management Information Classification · 1% confidence The document is a press release announcing a change in the company's Board of Directors: the co-optation of Pascal Touchon as an independent director and the retirement of Paul Sekhri. This directly relates to the composition and governance structure of the company's leadership. According to the definitions, announcements of changes in the company's board of directors or senior management fall under the 'Board/Management Information' category, which corresponds to the code MANG. The document is a formal announcement, not a full annual report (10-K), an earnings release (ER), or a proxy statement (PSI).
2023-09-04 French
Ipsen annonce un changement à la direction de sa R&D : Howard Mayer prend sa retraite et sera remplacé par Christelle Huguet
Board/Management Information Classification · 1% confidence The document is a press release from Ipsen announcing a significant change in senior management: the retirement of the Executive VP and Head of R&D (Howard Mayer) and the appointment of his successor (Christelle Huguet). This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2023-09-01 French
Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet
Board/Management Information Classification · 1% confidence The document is a press release titled "Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet." It details the succession plan for the Executive Vice President, Head of Research and Development role, including the effective dates and background of the incoming and outgoing executives. This content directly relates to changes in senior management and the board structure, fitting the definition of Board/Management Information (MANG). It is not a financial report (10-K, IR, ER), a proxy statement (DEF 14A), or a general regulatory filing (RNS).
2023-09-01 English
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2023
Director's Dealing Classification · 1% confidence The document text consists almost entirely of tables detailing transactions involving the issuer 'IPSEN' and an investment services provider ('Exane SA'). The tables include columns for 'Day of transaction', 'Identification code of financial instrument', 'Aggregated daily volume (in number of shares)', 'Price per transaction', and 'Purpose of buy back'. The presence of transaction dates, volumes, and prices, along with the explicit mention of 'buy back' purpose in one table structure, strongly indicates a report detailing personal share transactions by directors/executives or, more generally, transactions involving company shares by insiders or related parties. This aligns best with the definition for Director's Dealing (DIRS), which covers personal share transactions by directors and executives, or potentially Transaction in Own Shares (POS) if the transactions were exclusively buybacks/repurchases by the company itself. Given the structure detailing transactions by an external service provider (Exane SA) on specific dates, this is characteristic of mandatory disclosure filings related to insider or director transactions, which falls under DIRS (Director's Dealing).
2023-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.